[ad_1]
Collin M. Stultz, the Nina T. and Robert H. Rubin Professor in Medical Engineering and Science at MIT, has been named co-director of the Harvard-MIT Program in Well being Sciences and Know-how (HST), and affiliate director of MIT’s Institute for Medical Engineering and Science (IMES), efficient June 1. IMES is HST’s residence at MIT.
Stultz is a professor {of electrical} engineering and pc science at MIT, a core college member in IMES, a member of the HST college, and a working towards heart specialist at Massachusetts Basic Hospital (MGH). He’s additionally a member of the Analysis Laboratory of Electronics, and an affiliate member of the Laptop Science and Synthetic Intelligence Laboratory (CSAIL).
Anantha P. Chandrakasan, dean of the MIT College of Engineering and Vannevar Bush Professor of Electrical Engineering and Laptop Science, praised the appointment, saying “Professor Stultz’s exceptional management, dedication to instructing excellence, and unwavering devotion to pursuing developments in human well being, will undoubtedly assist to bolster and bolster the missions of each IMES and HST.”
Stultz is succeeding Emery N. Brown, who was first to function HST’s co-director at MIT, following the institution of IMES in 2012. (Wolfram Goessling is the co-director of HST at Harvard College.) Brown, the Edward Hood Taplin Professor of Medical Engineering and of Computational Neuroscience at MIT, will now be specializing in the institution of a brand new joint middle between MIT and MGH that can use the research of anesthesia to design novel approaches to controlling mind states, with a aim of bettering anesthesia and intensive care administration.
“It was a pleasure and honor for me to shepherd HST for the final 10 years,” Brown says. “I’m sure that Collin will probably be an outstanding co-director. He’s a extremely achieved scientist, a grasp clinician, and a dedicated educator.“
George Q. Daley, dean of Harvard Medical College and an HST alumnus, says, “I’m thrilled that HST’s new co-director will probably be a Harvard Medical College alumnus who accomplished scientific coaching and follow at our affiliated hospitals. Dr. Stultz’s exceptional experience in pc science and AI will engender constructive change as we reinvigorate this historic Harvard-MIT collaboration and redefine the scope of what it means to be a physician-scientist within the twenty first century.”
Elazer R. Edelman, the Edward J. Poitras Professor in Medical Engineering and Science and the director of IMES, additionally an HST alumnus, lauded the appointment, saying, “We’re so excited by the longer term, utilizing the unbelievable imaginative and prescient of Professor Stultz, his legacy of accomplishment, his dedication to mentorship, and his innate capacity to meld excellence in science and drugs, engineering, and physiology to propel us ahead. All the things Professor Stultz has executed predicates him and HST for fulfillment. “
Goessling says he seems ahead to working with Stultz in his new function. “I’ve recognized Collin since our residency days at Brigham and Ladies’s Hospital the place we cared for sufferers collectively. I’m actually excited to work collaboratively and synergistically with him to now maintain our college students collectively, to innovate our education schemes and proceed the legacy of success for HST.”
Stultz earned his BA magna cum laude in arithmetic and philosophy from Harvard College in 1988; a PhD in biophysics from Harvard in 1997; and an MD magna cum laude from Harvard Medical College, additionally in 1997. Stultz then went on to finish an internship and residency in inner drugs, adopted by a fellowship in cardiovascular drugs, on the Brigham and Ladies’s Hospital earlier than becoming a member of the school at MIT in 2004.
Stultz as soon as mentioned that his analysis focus at MIT is twofold: “the research of small issues you possibly can’t see with the bare eye, and the research of huge issues which you could,” and his scientific contributions have equally spanned a variety of size scales. As a graduate scholar within the laboratory of Martin Karplus — winner of the 2013 Nobel Prize in Chemistry — Stultz helped to develop computational strategies for designing ligands to versatile protein targets. As a junior college member at MIT, his group leveraged computational biophysics and experimental biochemistry to mannequin disordered proteins that play vital roles in human illness. Extra not too long ago, his analysis has targeted on the event and utility of machine studying strategies that allow well being care suppliers to realize perception into patient-specific physiology, utilizing scientific knowledge which are routinely obtained in each scientific and ambulatory settings.
Stultz is a member of the American Society for Biochemistry and Molecular Biology, the Federation of American Societies for Experimental Biology, and a fellow of the American Institute for Medical and Biomedical Engineering. He’s a previous recipient of an Irving M. London instructing award, a Nationwide Science Basis CAREER Award, a Burroughs Wellcome Fund Profession Award within the Biomedical Sciences, and he’s a current Phi Beta Kappa visiting scholar.
“Following within the footsteps of a scholar as famend as Emery Brown is daunting; nonetheless, I’m terribly optimistic about what HMS, HST, and MIT can accomplish within the years to come back,” Stultz says. “I look ahead to working with Elazer, Anantha, Wolfram, and the management at HMS to advance the tutorial mission of HST on the HMS campus, and all through the MIT ecosystem.”
[ad_2]
